用于精神分裂症的抗精神病药物联合治疗
Antipsychotic combinations for schizophrenia.
作者信息
Maayan Nicola, Soares-Weiser Karla, Xia Jun, Adams Clive E
机构信息
Enhance Reviews Ltd, Oxford, UK.
Cochrane Schizophrenia Group, University of Nottingham, Nottingham, UK.
出版信息
Cochrane Database Syst Rev. 2011(2). doi: 10.1002/14651858.CD009005.
Abstract
This is the protocol for a review and there is no abstract. The objectives are as follows: The primary objectives of this review are to examine whether: Treatment with antipsychotic combinations is effective for schizophrenia; andTreatment with antipsychotic combinations is safe for the same illness.
摘要
这是一项综述的方案，没有摘要。目标如下：本综述的主要目标是研究：抗精神病药物联合治疗对精神分裂症是否有效；以及抗精神病药物联合治疗对同一种疾病是否安全。
相似文献
1
Antipsychotic combinations for schizophrenia.
Cochrane Database Syst Rev. 2011(2). doi: 10.1002/14651858.CD009005.
2
Frequency and correlates of antipsychotic polypharmacy among patients with schizophrenia in Denmark: A nation-wide pharmacoepidemiological study.
Eur Neuropsychopharmacol. 2015 Oct;25(10):1669-76. doi: 10.1016/j.euroneuro.2015.04.027. Epub 2015 May 7.
3
Determinants of first- and second-generation antipsychotic drug use in clinically unstable patients with schizophrenia treated in four European countries.
Int Clin Psychopharmacol. 2006 Mar;21(2):73-9. doi: 10.1097/01.yic.0000185022.48279.db.
4
An examination of factors affecting persistence with initial antipsychotic treatment in patients with schizophrenia.
Curr Med Res Opin. 2007 Jan;23(1):97-104. doi: 10.1185/030079907X162665.
5
The acute efficacy of antipsychotics in schizophrenia: a review of recent meta-analyses.
Ther Adv Psychopharmacol. 2018 Oct 8;8(11):303-318. doi: 10.1177/2045125318781475. eCollection 2018 Nov.
6
[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
Encephale. 2005 Mar-Apr;31(2):235-46. doi: 10.1016/s0013-7006(05)82390-5.
7
Combined use of electroconvulsive therapy and antipsychotics in schizophrenia: the Indian evidence. A review and a meta-analysis.
J ECT. 2006 Mar;22(1):59-66. doi: 10.1097/00124509-200603000-00013.
8
Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews.
BMC Psychiatry. 2018 Sep 3;18(1):275. doi: 10.1186/s12888-018-1848-y.
9
Efficacy of 42 Pharmacologic Cotreatment Strategies Added to Antipsychotic Monotherapy in Schizophrenia: Systematic Overview and Quality Appraisal of the Meta-analytic Evidence.
JAMA Psychiatry. 2017 Jul 1;74(7):675-684. doi: 10.1001/jamapsychiatry.2017.0624.
10
Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies.
Neurosci Biobehav Rev. 2013 Sep;37(8):1680-91. doi: 10.1016/j.neubiorev.2013.06.001. Epub 2013 Jun 14.
引用本文的文献
1
Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews.
BMC Psychiatry. 2018 Sep 3;18(1):275. doi: 10.1186/s12888-018-1848-y.
2
Antipsychotic combinations for schizophrenia.
Cochrane Database Syst Rev. 2017 Jun 28;6(6):CD009005. doi: 10.1002/14651858.CD009005.pub2.
3
Aripiprazole versus other atypical antipsychotics for schizophrenia.
Cochrane Database Syst Rev. 2014 Jan 2;2014(1):CD006569. doi: 10.1002/14651858.CD006569.pub5.
本文引用的文献
1
Is the superior efficacy of new generation antipsychotics an artifact of LOCF?
Schizophr Bull. 2007 Jan;33(1):183-91. doi: 10.1093/schbul/sbl025. Epub 2006 Aug 11.
2
Imputing missing standard deviations in meta-analyses can provide accurate results.
J Clin Epidemiol. 2006 Jan;59(1):7-10. doi: 10.1016/j.jclinepi.2005.06.006.
3
Clinical implications of Brief Psychiatric Rating Scale scores.
Br J Psychiatry. 2005 Oct;187:366-71. doi: 10.1192/bjp.187.4.366.
4
What does the PANSS mean?
Schizophr Res. 2005 Nov 15;79(2-3):231-8. doi: 10.1016/j.schres.2005.04.008. Epub 2005 Jun 27.
5
Measuring inconsistency in meta-analyses.
BMJ. 2003 Sep 6;327(7414):557-60. doi: 10.1136/bmj.327.7414.557.
6
Lithium for schizophrenia.
Cochrane Database Syst Rev. 2003(3):CD003834. doi: 10.1002/14651858.CD003834.
7
Issues in the meta-analysis of cluster randomized trials.
Stat Med. 2002 Oct 15;21(19):2971-80. doi: 10.1002/sim.1301.
8
Electroconvulsive therapy for schizophrenia.
Cochrane Database Syst Rev. 2002(2):CD000076. doi: 10.1002/14651858.CD000076.
9
Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: implications for state mental health policy.
Schizophr Bull. 2002;28(1):75-84. doi: 10.1093/oxfordjournals.schbul.a006928.
10
Antipsychotic prescribing practices in Connecticut's public mental health system: rates of changing medications and prescribing styles.
Schizophr Bull. 2002;28(1):17-29. doi: 10.1093/oxfordjournals.schbul.a006920.
Zotero 插件